|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09939 KINTOR PHARMA-B
Nominal 
0.970 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (387,581) | (961,260) | (1,051,363) | (380,882) |
| Net Cash from / (used in) Investing Activities | -- | 3,274 | 67,195 | 92,005 | (439,728) |
| Net Cash from / (used in) Financing Activities | -- | (33,463) | 815,750 | 857,418 | 1,780,298 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (417,770) | (78,315) | (101,940) | 959,688 |
| Cash & Cash Equivalents at beginning of period | -- | 864,470 | 926,331 | 1,064,689 | 195,532 |
| Effect of Foreign Exchange Rate Changes | -- | (2,673) | 16,454 | (36,418) | (90,531) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 444,027 | 864,470 | 926,331 | 1,064,689 |
| Remarks: | Real time quote last updated: 27/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -71,493,000 |
| %Change | -66.295% |
| EPS / (LPS) | RMB -0.170 |
| NBV Per Share (¥) | RMB 0.875 |